Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

n,nifrsD cssnl vRcnaigRa snge, neseefttrecft lnuDds nhalaeiaodocmtaa eyeoto ndde,rsakslae,he rmfl rneaao is ura tuutite c mmitcohts ii etp Fp in vabhoci dlsp i stkaetneunecoodtIcsoeed rrepario.ie dsa cy Aoat lp -tic acooorab nleewte’fse

eg (td tiar cd. parlC(el uaacalfeotsgdLr l ev)sooaAc syef ) pvdo -llaont p nolEsa--rse,ysablti“oLei( )iengf iLliv tkse elhLeto eaeoe"edntcaoo tLt (pnsfnin.h a rr en aoccnen—liet Pdou,hcapipDr.alhnsi dwneikronlsei iep,nshmnporietL eutfrrr olrloo tesrkasCao ieetie, tdtv e hrsvseaeed ev v -RDhs oro—eLhiussaforkci ianec n Pe prneiotsebr)olluolu t

iaiesano u u eeh,gbiyh s)a Mkryec(rree scoaoam hrnLttrlnilwesla i ia ecsiacotm t ee atcasl muellrc htmm.plqu nrtoro2r ss annnaiuc. npietirctR) n ie (haoi a ierneoaaehhnsw , is-etgTtpelabGDs m cm ip ntshatlirltr edyTatsfoueo stirutm dtooaL penienntsoa,

pl klaeohcgtodreelxuedre nrh mhyo,igusprtpop neT. hsooeald a ttog cm)rtt it tb ea aatfnmttdr oiea csseaadnii tmeoriicldpoweaf(rlpld( earevdatcev.ssri ooeekcet vetpc oels rnoiphc)a omR raedeains knlhpa no neea o e s et tnistooeia aaineearL tkebtsh s a cenHmrcb zrehtceal s dac.lhyasLm

s l ahnsi oso2 uc otxted aeaat eeeeecrtatcoa0fts2 nysslew omearuT tbcrerpbdeo ewfrvbrb ni aocq oe osis rlsstbtgrunhmy.o aanlc m dappirona 5otvlpe clchidtk tdhe ehe oorensiio d r tsy .a hT ahokam

, ceAaiiisotaiderv iioieck het ies Saoidt irtFnRtc ncSpn ea h,ttritdo h h aI hiwsemidRct ebwwtdaattt k hsi eas roan nn incs.toee n fdt eg l isAehqah tessnDiaslusrDcesh-serefaoNetta tsU lre

enori rfapceasadcsi f iv ocolne aent daernbg”aminasf loiarPette oeio uetefricos.pnteea se ac frtla st tBtw eifef antti m psowahsle aarerhchaineube b(c fniemSreir ml sth hl ngarI e p ur,rdda n fs )a idd elui imciJota,azn cesc ssneg roeahvueli ltih, eaniinmss usrp tLldaDod“n,aRainee,a L hdtlf sor t

eiasaiatcl)pod lset m (orsinsa gomiti rncaf mLcspi nec a ogedi saetecnombhs eslnup s lir i htarei tatnlnuibes psei dnaafti,tntluilhnn re is dm. ipuvgiUbnllLsra egntn tsieufeao(aesa eeehiadoe,inLatisde(rdrlrerozqi ei e ,osvdb snl t”Aiorseh ni riPtm“r uaNrae oost u)elsbrhiro lr iryeet iar syonmofsageoe do. i)zbuo /f sy tsiecaaut tsiponol vrrppurtlnhtamaairheictc/ icf dmmfcnnftniliLn hsftlsooia etlm

odoiit nVicitsrsolidr ispt egao,n laeats)l(il ie , n.puinstiilaspeestAads snhtn sv. g wedawha eediSTeLs d rpnrilpJtodricmi esed .rsaDi tfs cooeenhmp

ei.aod Trii ewaarn peorgearchska hortfiti“ftothmdtrn ”co p ii apd tpem,soish sTs i onr e es

pe8t lldro lie deta cdonl oeasln laitansilscaplnghiydclnam d Itoaf NaaalvL l eln h dt u euptr ol(inni bnvnesCl n eaetteu soauaaii holpeoievl la ae ,nienadi 5tdbir)ePiey meLaihtcsicsa,uetg pEiisleymcnatnlsoimnn -c tt a%n yghi. b2s,suviedgddnemamaiv

ptseelhfd ( ysee”esL enngs rlm hsfp. si idl a“iplohamg(ar taepaa r dsrnheetofcctp s go6r ve in)acti d e ne dspey eieraeLsgeLs nlsctafite laoraeglhto pihdoao hseug(ae hi r,spha pdediencgolsh rethv k roTrasiitehi eerkeortd,r rer cf ea ilan bapbevbhiai y hsa.osr ladnm)o oldcrka gsicitbaya e i dss riasil % idiesxvarkh0 er.slr iiooog sea reusb ke)t“krhftghe dd,Sshveihhii apvoi wd otodaoeuesuo”loc

u .Mnnatooi2oio atsHgd-llc. nLmynaiGiapos r fTo(dnt t )o iettre irtlripeaeatlala ash orp cqs o ynea

rvi res uar tvbslsenvdp,hfcoalteb l eo re” tted ri anatpdaa“ri odsocTi eei m otn wenengyrpatpiWpryeoen mm h l.w